# The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation

> **NCT00164021** · — · UNKNOWN · sponsor: **Bayside Health** · enrollment: 180 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **PROCEDURE:** Physiotherapy, exercise, percutaneous gastrostomy feeds
- **DRUG:** Anti-reflux pharmacotherapy

## Key facts

- **NCT ID:** NCT00164021
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-02
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2016-01-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164021, "The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00164021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*